— Know what they know.
Not Investment Advice

GNPX NASDAQ

Genprex, Inc.
1W: -20.1% 1M: -25.1% 3M: -80.8% YTD: -93.3% 1Y: -98.7% 3Y: -100.0% 5Y: -100.0%
$2.63
+0.07 (+2.73%)
 
Weekly Expected Move ±11.8%
$2 $2 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 28 · $1.3M mcap · 480214 float · 34.83% daily turnover · Short 38% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +100.0% ▲
Operating Income
$0 +100.0% ▲
Net Income
-$16M +23.1% ▲
EPS (Diluted)
$-17.40 +93.5% ▲
EBITDA
$0 +100.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$23K$26K$15K$7K$0
Gross Profit-$23K-$26K-$15K-$7K$0
Gross Margin—————
R&D Expenses$9M$12M$18M$11M$9M
SG&A Expenses$12M$12M$13M$11M$6M
Operating Expenses$21M$24M$31M$21M$16M
Operating Income-$21M-$24M-$31M-$21M$0
Operating Margin—————
Interest Expense$0$0$0$0$0
Income Before Tax-$21M-$24M-$31M-$21M-$16M
Tax Expense$0$0$0$0$0
Net Income-$21M-$24M-$31M-$21M-$16M
Net Margin—————
EPS (Diluted)$-877.50$-990.00$-1128.00$-266.95$-17.40
EBITDA-$21M-$24M-$31M-$21M$0
Shares Outstanding23549239772735580119932730

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms